Gemvax Overview

  • Founded
  • 2001
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 2

Gemvax General Information

Description

Developer and manufacturer of pharmaceutical products. The company is focused on the development of peptide vaccines, which are innovative immunotherapeutic anti-cancer drugs.

Contact Information

Website
www.gemvax.com
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Acquirer
GemVax & Kael
Primary Office
  • Teknologisenteret
  • Kjølnes Ring
  • 3918 Porsgrunn
  • Norway
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Gemvax Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Gemvax‘s full profile, request access.

Request a free trial

Gemvax Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Gemvax‘s full profile, request access.

Request a free trial

Gemvax Subsidiaries (1)

Company Name Industry Location Founded
00000000 Electronic Components Daejeon, South Korea 0000
To view Gemvax’s complete subsidiaries history, request access »